NASDAQ: REGN · Biotechnology
Over the past week, Regeneron Pharmaceuticals (REGN) drew about 51 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 67% bullish but is far apart: News runs 91% bullish while X sits at just 50%. Wall Street is roughly in line with the crowd, with 18 of 28 analysts rating REGN a buy.
There is little buzz around REGN this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 64% buy share sits next to a crowd that ranges from X at 50% to News at 91%. No other tracker puts the two side by side.
Across 28 analysts the consensus is a Strong Buy: 18 buy calls against 1 sell, with an average 12-month price target of $849.32.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Buy.
Wall Street’s 64% buy share lands almost exactly on the crowd average of 67%. The split is inside the crowd: News reads 91% bullish while X sits at 50%, a 41-point spread that single-source trackers miss.
Over the 30-day window, Regeneron Pharmaceuticals (REGN) buzz held subdued around 37.7 while the price drifted down 2.9% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 626K shares. Over the last 7 trading days, REGN lost 8.3%. Buzz activity in the recent week averaged 35.6 and was variable, swinging between 13.3 and 46.0. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 16 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for REGN and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live REGN sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 11, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (18 / 9 / 1) |
| Crowd bullish (7d) | 67% |
| Avg price target | $849.32 |
| Most bullish source | News, 91% |
| Most bearish source | X, 50% |
| Sentiment spread | 41 pts |
| Mentions (7d) | 51 |
| Market cap | $81.67B |
| P/E · Forward P/E | 20.0 · 14.6 |
| EPS · Beta | $39.66 · 0.2 |
| Revenue (TTM) | $15.53B · 28% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Regeneron Pharmaceuticals (REGN) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 67% bullish across 3 active sources. Those sources contribute 51 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Regeneron Pharmaceuticals (REGN) is fairly quiet with 5 mentions over the last 7 days; the 30-day context spans 8 tracked subreddits. The 7-day tone is 60% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads bullish on Regeneron Pharmaceuticals (REGN), averaging 67% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 91% bullish and X at 50%, a 41-point spread. On the professional side, 18 of 28 analysts rate REGN a buy.
Of the 28 analysts covering Regeneron Pharmaceuticals (REGN), 18 rate it a buy, 9 a hold and 1 a sell, for a strong buy consensus. The average price target is $849.32. That lines up with the crowd average of 67% bullish.
Regeneron Pharmaceuticals (REGN)'s cross-source average is bullish at 67% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. Reddit reads 60% bullish, News reads 91% bullish and x coverage is the most negative at 50% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Regeneron Pharmaceuticals (REGN) at 67% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. The most bearish reading is x at 50% bullish. 3-day activity momentum is falling across Reddit and X and News. The buy signal carries 93/100 conviction.
News is the dominant discussion channel with 32 mentions (63% of total volume). X contributes 14 mentions and Reddit contributes 5 mentions. The cross-source average is bullish at 67% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. REGN's buy signal at 93/100 conviction reflects a bullish cross-source average at 67% bullish. Source readings are split: 2 sources lean bullish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The REGN sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key